Abstract
COVID-19 is a significant global health burden. The pulmonary morbidity and mortality of COVID-19 is well described, however, there is mounting evidence of neurological manifestations of SARS-CoV-2, which may be of prognostic significance. This paper summarises the available evidence in order to provide clinicians with a concise summary of the peripheral and central neurological manifestations of COVID-19, discusses specific issues regarding the management of chronic neurological disease in the context of the pandemic, and provides a summary of the thrombotic implications of the disease for the neurologist.
Subject
Neurology (clinical),Neurology
Reference43 articles.
1. The COVID-19 pandemic: territorial, political and governance dimensions of the crisis;Dodds;Territ Politic Gov,2020
2. Australian Government Department of Health . Coronavirus (COVID-19) current situation and case numbers Australia: Australian government department of health, 2020. Available: https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-current-situation-and-case-numbers#total-cases-recoveries-deaths-and-new-cases-in-the-last-24-hours [Accessed 25 Oct 2020].
3. Worldometer . COVID-19 coronavirus pandemic: coronavirus cases, 2020. Available: https://www.worldometers.info/coronavirus/ [Accessed 25 Oct 2020].
4. Ellul MA , Benjamin L , Singh B , et al . Neurological associations of COVID-19. Lancet Neurol 2020.
5. Garg RK , Paliwal VK , Gupta A . Encephalopathy in patients with COVID‐19: a review. J Med Virol 2020;0140.doi:10.1002/jmv.26207
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献